Literature DB >> 12660825

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.

Hiroyuki Konishi1, Miyabi Sugiyama, Kotaro Mizuno, Hiroko Saito, Yasushi Yatabe, Toshitada Takahashi, Hirotaka Osada, Takashi Takahashi.   

Abstract

17p13.3 is one of the chromosomal regions most frequently affected by allelic loss in a variety of human neoplasms including lung cancer. A number of loss of heterozygosity (LOH) analyses have suggested the existence of a tumor suppressor gene at 17p13.3, distal to the p53 locus at 17p13.1. In the present study, we characterized a homozygous deletion at 17p13.3 in a small cell lung cancer cell line by constructing a bacterial artificial chromosome (BAC) contig and a restriction map surrounding the region, as well as by utilizing publicly available draft sequences. We defined the breakpoint, assigned and analysed two known genes, 14-3-3 epsilon and CRK, and a novel gene LOST1 within or at the end of the homozygous deletion of about 170 kb in size. Marked reduction of LOST1 expression was detected in 69% (11/16) of lung cancer specimens by quantitative real-time RT-PCR, while significant DNA hypermethylation was observed at the 5' end of the LOST1 gene in four of six lung cancer cell lines with negligible LOST1 expression. We also show here that a polymorphic marker D17S1174, which resides within the homozygous deletion, was apparently located in the middle of the minimum LOH region, providing further supportive evidence for the presence of a tumor suppressor gene(s) in this region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660825     DOI: 10.1038/sj.onc.1206304

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis.

Authors:  James D Bortner; Arunangshu Das; Todd M Umstead; Williard M Freeman; Richard Somiari; Cesar Aliaga; David S Phelps; Karam El-Bayoumy
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

2.  Molecular Characterization of the Tumor Suppressor Candidate 5 Gene: Regulation by PPARgamma and Identification of TUSC5 Coding Variants in Lean and Obese Humans.

Authors:  Trina A Knotts; Hyun Woo Lee; Jae Bum Kim; Pieter J Oort; Ruth McPherson; Robert Dent; Keisuke Tachibana; Takefumi Doi; Songtao Yu; Janardan K Reddy; Kenji Uno; Hideki Katagiri; Magdalena Pasarica; Steven R Smith; Dorothy D Sears; Michel Grino; Sean H Adams
Journal:  PPAR Res       Date:  2010-03-01       Impact factor: 4.964

3.  Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma.

Authors:  Heike Stöcklein; Grit Hutter; Jörg Kalla; Elena Hartmann; Yvonne Zimmermann; Tiemo Katzenberger; Patrick Adam; Ellen Leich; Sylvia Höller; Hans Konrad Müller-Hermelink; Andreas Rosenwald; German Ott; Martin Dreyling
Journal:  J Hematop       Date:  2008-07-05       Impact factor: 0.196

4.  Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.

Authors:  Carola Hedberg Oldfors; Diego Garcia Dios; Anna Linder; Kittichate Visuttijai; Emma Samuelson; Sandra Karlsson; Staffan Nilsson; Afrouz Behboudi
Journal:  BMC Genet       Date:  2015-07-14       Impact factor: 2.797

5.  GnRH antagonist treatment of malignant adrenocortical tumors.

Authors:  Milena Doroszko; Marcin Chrusciel; Joanna Stelmaszewska; Tomasz Slezak; Slawomir Anisimowicz; Ursula Plöckinger; Marcus Quinkler; Marco Bonomi; Slawomir Wolczynski; Ilpo Huhtaniemi; Jorma Toppari; Nafis A Rahman
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

6.  Expression and clinical significance of HCCS1 in non-small cell lung cancer.

Authors:  Shen Xiao-Yong; Lin Zhi-Feng; Lu Fan-Zhen; Ruan Zhen; Zhen Jian; Huang Hai-Long; Ju Chao-Qiang
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29

7.  Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes.

Authors:  Daniel J Fazakerley; Sheyda Naghiloo; Rima Chaudhuri; Françoise Koumanov; James G Burchfield; Kristen C Thomas; James R Krycer; Matthew J Prior; Ben L Parker; Beverley A Murrow; Jacqueline Stöckli; Christopher C Meoli; Geoffrey D Holman; David E James
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

8.  Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT.

Authors:  Kittichate Visuttijai; Jennifer Pettersson; Yashar Mehrbani Azar; Iman van den Bout; Charlotte Örndal; Janusz Marcickiewicz; Staffan Nilsson; Michael Hörnquist; Björn Olsson; Katarina Ejeskär; Afrouz Behboudi
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

9.  miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.

Authors:  Xi Jiang; Chao Hu; Stephen Arnovitz; Jason Bugno; Miao Yu; Zhixiang Zuo; Ping Chen; Hao Huang; Bryan Ulrich; Sandeep Gurbuxani; Hengyou Weng; Jennifer Strong; Yungui Wang; Yuanyuan Li; Justin Salat; Shenglai Li; Abdel G Elkahloun; Yang Yang; Mary Beth Neilly; Richard A Larson; Michelle M Le Beau; Tobias Herold; Stefan K Bohlander; Paul P Liu; Jiwang Zhang; Zejuan Li; Chuan He; Jie Jin; Seungpyo Hong; Jianjun Chen
Journal:  Nat Commun       Date:  2016-04-26       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.